clarithromycin has been researched along with Gastritis, Atrophic in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (12.00) | 18.2507 |
2000's | 11 (44.00) | 29.6817 |
2010's | 8 (32.00) | 24.3611 |
2020's | 3 (12.00) | 2.80 |
Authors | Studies |
---|---|
Cao, LJ; Cao, WL; Che, Y; Ding, CJ; Huang, H; Wang, Y; Wu, JW; Xu, WF; Zhang, Q | 1 |
Bernardino, JI; Martín Carbonero, L; Montejano, R; Moreno, V; Serrano, L; Valencia, ME | 1 |
Fukuda, K; Fukuda, M; Hirashita, Y; Kawahara, Y; Kodama, M; Kudo, Y; Matsunari, O; Mizukami, K; Murakami, K; Ogawa, R; Okamoto, K; Okimoto, T; Wada, Y | 1 |
Cho, SJ; Choi, IJ; Kim, CG; Kim, YI; Kook, MC; Lee, JY; Nam, BH; Park, B | 1 |
Cui, R; Ding, S; Guo, C; Huang, X; Jin, Z; Li, Y; Lin, S; Meng, L; Xue, Y; Yan, X; Zhang, J; Zhang, L; Zhou, L | 1 |
Inoue, S; Itagaki, T; Kagemoto, K; Mitsui, Y; Muguruma, N; Naruse, K; Takayama, T | 1 |
Becquart, JP; Camuset, G; Gérardin, P; Guillemot, G; Jaubert, J; Kwiatek, S; Michault, A; Picot, S; Thomas, E; Zemali, N | 1 |
Inoue, H; Ito, M; Kasai, C; Moritani, I; Oya, Y; Shiraki, K; Sugimoto, K; Takase, K; Takei, Y; Tameda, M; Tanaka, J | 1 |
Bravo, JC; Bravo, LE; Casabon, AL; Casabon, LA; Collazos, T; Correa, P; Fischbach, LA; Guerrero, LZ; Ojha, PR; Ojha, RP; Priest, EL; Singh, KP; Singh, PK; Zarama, GR | 1 |
Fujioka, T; Kodama, M; Murakami, K; Okimoto, T; Sato, R; Watanabe, K | 1 |
Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, MS; Kim, N; Kim, SE; Lee, DH; Lee, SH; Park, YS; Shin, CM | 1 |
Hibi, T; Nishizawa, T; Suzuki, H; Tsugawa, H | 1 |
Asaka, M; Shimodan, M; Sugiyama, T; Tsuchida, M; Yokota, K | 1 |
Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Ley, C; Mohar, A; Parsonnet, J | 1 |
Schuster, MJ | 1 |
Bielanski, W; Galuschka, K; Hahn, EG; Karcz, D; Konturek, PC; Konturek, SJ; Rembiasz, K; Stachura, J | 1 |
Asaka, M | 1 |
Haruma, K; Hata, J; Ito, M; Kamada, T; Kusunoki, H; Sasaki, A; Tanaka, S; Yoshihara, M | 1 |
Schuster, M | 1 |
Hershko, C; Hoffbrand, AV; Keret, D; Lahad, A; Maschler, I; Monselise, Y; Souroujon, M | 1 |
Burette, A; Glupczynski, Y | 1 |
Fujioka, T; Kubota, T; Murakami, K; Sato, R | 1 |
Asaka, M; Hirayama, Y; Nakamura, T; Takahashi, S; Uemura, N | 1 |
Bloemena, E; Festen, HP; Klinkenberg-Knol, EC; Kuipers, EJ; Lindeman, J; Luckers, AE; Meuwissen, SG; Nelis, GF; Schenk, BE; Snel, P; Thijs, JC; Viergever, PP | 1 |
Bazzoli, F; Bianchi Porro, G; Bianchi, MG; Molteni, M; Pazzato, P; Zagari, RM | 1 |
7 review(s) available for clarithromycin and Gastritis, Atrophic
Article | Year |
---|---|
Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Gene Expression Regulation, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Virulence | 2012 |
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Follow-Up Studies; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Risk; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Time Factors | 2002 |
[Guidelines in the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Microbiology; Omeprazole; Peptic Ulcer; Polyps; Practice Guidelines as Topic; Proton Pump Inhibitors; Societies, Medical; Stomach Neoplasms | 2003 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Neoplasms | 2004 |
Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Treatment Outcome; Uncoupling Agents | 1995 |
[Problems following antibiotic therapy for eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Esophagitis, Peptic; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 1998 |
Treatment of Helicobacter pylori infection. Indications and regimens: an update.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Practice Guidelines as Topic; Ranitidine | 2002 |
6 trial(s) available for clarithromycin and Gastritis, Atrophic
Article | Year |
---|---|
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Topics: Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis, Atrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Stomach; Stomach Neoplasms | 2018 |
Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stomach Neoplasms | 2014 |
A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Colombia; Developing Countries; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Single-Blind Method; Treatment Outcome | 2009 |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Topics: Adenocarcinoma; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastrins; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Penicillins; Precancerous Conditions; Recurrence; Risk Factors; ROC Curve; Stomach Neoplasms | 2002 |
The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2003 |
Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Esophagitis, Peptic; Female; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies | 2000 |
12 other study(ies) available for clarithromycin and Gastritis, Atrophic
Article | Year |
---|---|
Octreotide-based therapies effectively protect mice from acute and chronic gastritis.
Topics: Animals; Clarithromycin; Ethanol; Gastric Mucosa; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Inflammation; Male; Mice; Mice, Inbred C57BL; Octreotide; Omeprazole | 2022 |
[Helicobacter pylori infection in the HIV + population: a comorbidity to think about].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Ulcer Agents; Clarithromycin; Comorbidity; Drug Therapy, Combination; Dyspepsia; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Spain | 2020 |
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Sex Factors; Young Adult | 2021 |
Gastric inflammatory fibroid polyp morphologically changed by Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Endoscopy, Digestive System; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polyps; Proton Pump Inhibitors; Rabeprazole; Stomach Neoplasms | 2015 |
Helicobacter pylori resistance to clarithromycin in Reunion Island.
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Gastric Fundus; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Mutation; Proton Pump Inhibitors; Pyloric Antrum; Reunion; Stomach Neoplasms | 2016 |
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Body Mass Index; Body Weight; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis, Atrophic; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leptin; Male; Middle Aged; Peptic Ulcer | 2016 |
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Pepsinogens; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2011 |
Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Recurrence; Republic of Korea; Risk Factors; Socioeconomic Factors; Young Adult | 2013 |
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Hematologic Tests; Humans; Lansoprazole; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; Gastric Mucosa; Gastrins; Gastritis, Atrophic; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Omeprazole; Ornithine Decarboxylase; Peroxidases; Prostaglandin-Endoperoxide Synthases; RNA, Messenger | 2003 |
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Antibodies, Bacterial; Autoantibodies; Autoimmune Diseases; Bacterial Proteins; Breath Tests; Celiac Disease; Child; Clarithromycin; Comorbidity; Drug Therapy, Combination; Female; Ferrous Compounds; Gastrins; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Prospective Studies; Urease; Vitamin B 12 Deficiency | 2005 |
[Topics on Helicobacter pylori (discussion)].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Stomach Neoplasms | 1998 |